Analyst stock forecast
Abivax Forecast: $163.58 Analyst Target
Direct answer
Abivax's average price target is $163.58.
The target implies +81.4% from the recorded current price, and the consensus rating is none.
The low target implies +57.4%, the high target implies +100.7%, and the range spans 43.2% of the current price.
Forecast evidence checked November 13, 2026.
Get free Abivax email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $90.20
- Average price target
- $163.58
- High price target
- $181.00
- Low price target
- $142.00
- Low target gap
- +57.4%
- Target upside
- +81.4%
- High target gap
- +100.7%
- Target range width
- 43.2%
- Consensus rating
- none
- Analysts
- 12
- Evidence date
- November 13, 2026
- Valid through
- November 20, 2026
Explore related company data
Read the frequently asked questions.
What is Abivax's average price target?
Abivax's verified average price target is $163.58. The target range is $142.00 to $181.00.
How far are Abivax's low and high targets from the recorded price?
The low target implies +57.4%, while the high target implies +100.7%.
How many analysts are included in Abivax's consensus?
The verified consensus includes 12 analysts.
How is Abivax's target upside or downside calculated?
The average target of $163.58 is divided by the recorded price of $90.20, then one is subtracted to produce +81.4%. This does not guarantee a future return.
When was Abivax's analyst forecast verified?
The data was verified on 2026-11-13. The dataset is valid through 2026-11-20.